Rapid hepatic metabolism of 7-ketocholesterol by 11beta-hydroxysteroid dehydrogenase type 1: species-specific differences between the rat, human, and hamster enzyme.

The role of 11beta-hydroxysteroid dehydrogenase type 1 (11beta-HSD1) in the local activation of the glucocorticoid receptor by converting inactive 11-ketoglucocorticoids to active 11beta-hydroxyglucocorticoids is well established. Currently, 11beta-HSD1 is considered a promising target for treatment of obese and diabetic patients. Here, we demonstrate a role of 11beta-HSD1 in the metabolism of 7-ketocholesterol (7KC), the major dietary oxysterol. Comparison of recombinant 11beta-HSD1, transiently expressed in human embryonic kidney 293 cells, revealed the stereo-specific interconversion of 7KC and 7beta-hydroxycholesterol by rat and human 11beta-HSD1, whereas the hamster enzyme interconverted 7alpha-hydroxycholesterol, 7beta-hydroxycholesterol, and 7KC. In contrast to lysates, which efficiently catalyzed both oxidation and reduction, intact cells exclusively reduced 7KC. These findings were confirmed using rat and hamster liver homogenates, intact rat hepatocytes, and intact hamster liver tissue slices. Reduction of 7KC was abolished upon inhibition of 11beta-HSD1 by carbenoxolone (CBX) or 2'-hydroxyflavanone. In vivo, after gavage feeding rats, 7KC rapidly appeared in the liver and was converted to 7beta-hydroxycholesterol. CBX significantly decreased the ratio of 7beta-hydroxycholesterol to 7KC, supporting the evidence from cell culture experiments for 11beta-HSD1-dependent reduction of 7KC to 7beta-hydroxycholesterol. Upon inhibition of 11beta-HSD1 by CBX, 7KC tended to accumulate in the liver, and plasma 7KC concentration increased. Together, our results suggest that 11beta-HSD1 efficiently catalyzes the first step in the rapid hepatic metabolism of dietary 7KC, which may explain why dietary 7KC has little or no effect on the development of atherosclerosis.

[1]  A. Odermatt,et al.  A rapid screening assay for inhibitors of 11β-hydroxysteroid dehydrogenases (11β-HSD): flavanone selectively inhibits 11β-HSD1 reductase activity , 2003, Molecular and Cellular Endocrinology.

[2]  Y. Yamaoka,et al.  Carbenoxolone inhibits DNA synthesis and collagen gene expression in rat hepatic stellate cells in culture. , 2003, Journal of hepatology.

[3]  Ruben Coronel,et al.  Conduction slowing by the gap junctional uncoupler carbenoxolone. , 2003, Cardiovascular research.

[4]  L. Abrahmsén,et al.  Selective inhibition of 11 beta-hydroxysteroid dehydrogenase type 1 improves hepatic insulin sensitivity in hyperglycemic mice strains. , 2003, Endocrinology.

[5]  J. Bunt,et al.  Subcutaneous adipose 11 beta-hydroxysteroid dehydrogenase type 1 activity and messenger ribonucleic acid levels are associated with adiposity and insulinemia in Pima Indians and Caucasians. , 2003, The Journal of clinical endocrinology and metabolism.

[6]  R. Prough,et al.  Glucocorticoids inhibit interconversion of 7-hydroxy and 7-oxo metabolites of dehydroepiandrosterone: a role for 11beta-hydroxysteroid dehydrogenases? , 2003, Archives of biochemistry and biophysics.

[7]  B. Walker,et al.  Is 11β-Hydroxysteroid Dehydrogenase Type 1 a Therapeutic Target? Effects of Carbenoxolone in Lean and Obese Zucker Rats , 2003, Journal of Pharmacology and Experimental Therapeutics.

[8]  L. Skálová,et al.  Stereochemical aspects of carbonyl reduction of the original anticancer drug oracin by mouse liver microsomes and purified 11beta-hydroxysteroid dehydrogenase type 1. , 2003, Chemico-biological interactions.

[9]  E. Maser,et al.  Purification, characterization and NNK carbonyl reductase activities of 11beta-hydroxysteroid dehydrogenase type 1 from human liver: enzyme cooperativity and significance in the detoxification of a tobacco-derived carcinogen. , 2003, Chemico-biological interactions.

[10]  F. Violi,et al.  Measurement of oxysterols and alpha-tocopherol in plasma and tissue samples as indices of oxidant stress status. , 2003, Analytical biochemistry.

[11]  Hiroko Tomoyori,et al.  Dietary cholesterol-oxidation products accumulate in serum and liver in apolipoprotein E-deficient mice, but do not accelerate atherosclerosis , 2002, British Journal of Nutrition.

[12]  L. Abrahmsén,et al.  Arylsulfonamidothiazoles as a new class of potential antidiabetic drugs. Discovery of potent and selective inhibitors of the 11beta-hydroxysteroid dehydrogenase type 1. , 2002, Journal of medicinal chemistry.

[13]  Y. Ohta,et al.  A comparative study of the conversion of 7-hydroxycholesterol in rabbit, guinea pig, rat, hamster, and chicken , 2002, Steroids.

[14]  B. Vogt,et al.  Glucocorticoids and 11β‐hydroxysteroid dehydrogenase type 2 gene expression in the aging kidney , 2002, European journal of clinical investigation.

[15]  L. Beilin,et al.  Effect of dietary cholesterol oxidation products on the plasma clearance of chylomicrons in the rat , 2002, Lipids.

[16]  N. Maeda,et al.  Paradoxical enhancement of hepatic metabolism of 7-ketocholesterol in sterol 27-hydroxylase-deficient mice. , 2002, Biochimica et biophysica acta.

[17]  J. Flier,et al.  A Transgenic Model of Visceral Obesity and the Metabolic Syndrome , 2001, Science.

[18]  W. Pierce,et al.  Metabolism of DHEA by cytochromes P450 in rat and human liver microsomal fractions. , 2001, Archives of biochemistry and biophysics.

[19]  M. Lyons,et al.  7-Ketocholesterol delivered to mice in chylomicron remnant-like particles is rapidly metabolised, excreted and does not accumulate in aorta. , 2001, Biochimica et biophysica acta.

[20]  G. Watts,et al.  Sterol 27-hydroxylase acts on 7-ketocholesterol in human atherosclerotic lesions and macrophages in culture , 2000 .

[21]  A. Odermatt,et al.  The N-terminal Anchor Sequences of 11β-Hydroxysteroid Dehydrogenases Determine Their Orientation in the Endoplasmic Reticulum Membrane* , 1999, The Journal of Biological Chemistry.

[22]  S. Samman,et al.  Rapid hepatic metabolism of 7-ketocholesterol in vivo: implications for dietary oxysterols. , 1999, Journal of lipid research.

[23]  Andrew J. Brown,et al.  Oxysterols and atherosclerosis. , 1999, Atherosclerosis.

[24]  W. Dean,et al.  Purification and Characterization of Hamster Liver Microsomal 7α-Hydroxycholesterol Dehydrogenase , 1998, The Journal of Biological Chemistry.

[25]  K. Takeuchi,et al.  Stimulation of duodenal bicarbonate secretion by carbenoxolone in rats: a comparative study with prostaglandin E2. , 1998, General pharmacology.

[26]  L. Beilin,et al.  Absorption of dietary cholesterol oxidation products and incorporation into rat lymph chylomicrons , 1997, Lipids.

[27]  R. Dean,et al.  Sterol Efflux Is Impaired from Macrophage Foam Cells Selectively Enriched with 7-Ketocholesterol* , 1996, The Journal of Biological Chemistry.

[28]  L. Skibsted,et al.  Isolation and quantification of cholesterol oxides in dairy products by selected ion monitoring mass spectrometry , 1995, Journal of Dairy Research.

[29]  N. Javitt.  Bile acid synthesis from cholesterol: regulatory and auxiliary pathways , 1994, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[30]  W. Griffiths,et al.  Positions of conjugation of bile acids with glucose and N-acetylglucosamine in vitro. , 1994, Journal of lipid research.

[31]  M. Hayakari,et al.  The effect of dietary 7-ketocholesterol, inhibitor of sterol synthesis, on hepatic microsomal cholesterol 7 alpha-hydroxylase activity in rat. , 1994, Biochimica et biophysica acta.

[32]  M. Sugano,et al.  Lymphatic absorption of oxidized cholesterol in rats , 1994, Lipids.

[33]  P. Stewart,et al.  11 beta-Hydroxysteroid dehydrogenase. , 1994, Vitamins and hormones.

[34]  J. Chiang,et al.  Cholesterol 7 alpha-hydroxylase is up-regulated by the competitive inhibitor 7-oxocholesterol in rat liver. , 1993, European journal of biochemistry.

[35]  J. Rothuizen,et al.  A species comparison of tolbutamide metabolism in precision-cut liver slices from rats and dogs. Qualitative and quantitative sex differences. , 1993, Drug metabolism and disposition: the biological fate of chemicals.

[36]  S. Matern,et al.  Bile acid N-acetylglucosaminidation. In vivo and in vitro evidence for a selective conjugation reaction of 7 beta-hydroxylated bile acids in humans. , 1992, The Journal of clinical investigation.

[37]  M. Osame,et al.  Atherogenic risk factors in cerebrotendinous xanthomatosis. , 1991, Clinica chimica acta; international journal of clinical chemistry.

[38]  A. Sevanian,et al.  Cholesterol feeding increases plasma and aortic tissue cholesterol oxide levels in parallel: further evidence for the role of cholesterol oxidation in atherosclerosis. , 1991, Atherosclerosis.

[39]  S. Erickson,et al.  7-Ketocholesterol. Its effects on hepatic cholesterogenesis and its hepatic metabolism in vivo and in vitro. , 1977, The Journal of biological chemistry.

[40]  T. Norri,et al.  Metabolism of 7-Hydroxycholesterol-4-C in rat , 1970 .

[41]  B. Walker,et al.  Effects of the 11β-Hydroxysteroid Dehydrogenase Inhibitor Carbenoxolone on Insulin Sensitivity in Men with Type 2 Diabetes , 2003 .

[42]  G. Schroepfer,et al.  Oxysterols: modulators of cholesterol metabolism and other processes. , 2000, Physiological reviews.

[43]  N. Chai,et al.  Inhibitory effect of cholesterol oxides on low density lipoprotein receptor gene expression. , 1996, Artery.

[44]  K. Einarsson,et al.  Formation and metabolism of 3-beta-hydroxycholest-5-en-7-one and cholest-5-ene-3-beta, 7-beta-diol. Bile acids and steroids 192. , 1968, Acta chemica Scandinavica.